Discontinuation report TRANSDERM-NITRO 0.6
Report ID | 138767 |
Drug Identification Number | 02046156 |
Brand name | TRANSDERM-NITRO 0.6 |
Common or Proper name | TRANSDER-NITRO 0.6 PATCH 30 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NITROGLYCERIN |
Strength(s) | 0.6MG |
Dosage form(s) | PATCH (EXTENDED RELEASE) |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 30 |
ATC code | C01DA |
ATC description | VASODILATORS USED IN CARDIAC DISEASES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-08-31 |
Actual discontinuation date | 2021-09-02 |
Remaining supply date | 2022-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-05-05 | English | Compare |
v2 | 2021-05-05 | French | Compare |
v3 | 2021-05-05 | English | Compare |
v4 | 2021-05-05 | French | Compare |
v5 | 2022-01-17 | English | Compare |
v6 | 2022-01-17 | French | Compare |
Showing 1 to 6 of 6